Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome
Clinical trial NCT00955630 · UNKNOWN
Trial details
- NCT number
- NCT00955630
- Sponsor
- Retina Associates of Kentucky
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-08-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.